Last reviewed · How we verify
Fetal porcine cells, Neurocell-PD — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Fetal porcine cells, Neurocell-PD (Fetal porcine cells, Neurocell-PD) — Genzyme, a Sanofi Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Fetal porcine cells, Neurocell-PD TARGET | Fetal porcine cells, Neurocell-PD | Genzyme, a Sanofi Company | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Fetal porcine cells, Neurocell-PD CI watch — RSS
- Fetal porcine cells, Neurocell-PD CI watch — Atom
- Fetal porcine cells, Neurocell-PD CI watch — JSON
- Fetal porcine cells, Neurocell-PD alone — RSS
Cite this brief
Drug Landscape (2026). Fetal porcine cells, Neurocell-PD — Competitive Intelligence Brief. https://druglandscape.com/ci/fetal-porcine-cells-neurocell-pd. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab